Detalhe da pesquisa
1.
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis.
Blood
; 143(13): 1259-1268, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194690
2.
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy.
Circulation
; 149(15): 1157-1168, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328945
3.
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime.
Br J Haematol
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38840512
4.
Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker.
Clin Auton Res
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769233
5.
Conventional heart failure therapy in cardiac ATTR amyloidosis.
Eur Heart J
; 44(31): 2893-2907, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216684
6.
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis.
Eur Heart J
; 44(24): 2187-2198, 2023 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36946431
7.
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years.
Circulation
; 146(22): 1657-1670, 2022 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36325894
8.
Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light-chain amyloidosis.
Br J Haematol
; 201(3): 422-431, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709756
9.
Characteristics and natural history of early-stage cardiac transthyretin amyloidosis.
Eur Heart J
; 43(27): 2622-2632, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608040
10.
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.
Eur Heart J
; 43(4): 333-341, 2022 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472567
11.
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.
Eur Heart J
; 43(45): 4722-4735, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239754
12.
AMYLOIDOSIS IN CAPTIVE EUROPEAN EASTERN BONGO (TRAGELAPHUS EURYCERUS ISAACI): PREVALENCE, PREDICTIVE FACTORS, ORGAN PREDILECTION, AND SERUM AMYLOID A CONCENTRATIONS.
J Zoo Wildl Med
; 53(4): 696-704, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640071
13.
Clinical ApoA-IV amyloid is associated with fibrillogenic signal sequence.
J Pathol
; 255(3): 311-318, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331462
14.
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal data.
Br J Haematol
; 194(3): 587-597, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34189728
15.
Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis.
Br J Haematol
; 194(6): 1016-1023, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374069
16.
Antibody-Associated Reversal of ATTR Amyloidosis-Related Cardiomyopathy.
N Engl J Med
; 388(23): 2199-2201, 2023 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37285532
17.
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
N Engl J Med
; 379(1): 11-21, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972753
18.
A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib.
Blood
; 134(25): 2271-2280, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578202
19.
Renal transplant outcomes in amyloidosis.
Nephrol Dial Transplant
; 36(2): 355-365, 2021 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439995
20.
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.
Eur J Haematol
; 106(4): 537-545, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460466